Skip to main content

Want a detailed portfolio tracker?

Revelation Biosciences (REVB) P/E (2024 - 2026)

Revelation Biosciences (REVB) P/E from Apr 1, 2024 to Jul 21, 2026. The TTM Revelation Biosciences (REVB) P/E is -0.25. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Revelation Biosciences (REVB)

YearP/EChange
2026-0.25-21.69%
2025-0.32-82.41%
2024-1.79N/A

Comparison Revelation Biosciences (REVB) P/E with competitors

Revelation Biosciences (REVB) P/E is -0.25.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.69%
NBYStablecoin Development Corp0.00-101.74%
ENLVEnlivex Ltd0.07-130.31%
FGENFibroGen Inc0.24-197.27%
CHRSCoherus Biosciences Inc0.85-443.85%
FBIOFortress Biotech Inc0.95-484.57%
ORMPOramed Pharmaceuticals Inc1.50-709.08%
AGENAgenus Inc3.01-1319.57%
INVAInnoviva Inc3.15-1378.09%
VXRTVaxart Inc3.55-1538.45%
CRMDCorMedix Inc3.63-1570.34%
CVACCureVac N.V.4.45-1901.50%
GLPGGalapagos NV4.86-2068.95%
SRPTSarepta Therapeutics Inc4.88-2078.35%
ABEOAbeona Therapeutics Inc5.39-2283.16%
ABUSArbutus Biopharma Corp5.60-2367.49%
ZVRAZevra Therapeutics Inc5.89-2485.66%
SPROSpero Therapeutics Inc6.23-2623.92%
CGENCompugen Ltd6.31-2658.57%
RIGLRigel Pharmaceuticals6.87-2884.74%
SLXNSilexion Therapeutics Corp7.30-3056.56%
OMEROmeros Corporation9.26-3851.89%
AUPHAurinia Pharmaceuticals Inc9.58-3984.08%
PLXProtalix BioTherapeutics Inc10.89-4513.32%
ACADAcadia Pharmaceuticals Inc11.73-4852.71%
TBPHTheravance Biopharma Inc12.26-5068.95%
ADMAAdma Biologics Inc12.42-5132.17%
HRMYHarmony Biosciences Holdings Inc13.82-5700.32%
SABSSAB Biotherapeutics Inc14.14-5828.37%
NAGENiagen Bioscience Inc14.82-6104.71%
INCYIncyte Corp15.82-6511.73%
REGNRegeneron Pharmaceuticals Inc15.86-6525.55%
PBYIPuma Biotechnology Inc17.32-7116.80%
CPRXCatalyst Pharmaceuticals Inc17.44-7166.88%
EXELExelixis Inc17.54-7206.88%
TGTXTG Therapeutics Inc18.97-7785.57%
MDXGMimedx Group Inc20.55-8428.44%
XOMAXOMA Royalty Corp22.87-9369.70%
ARGXArgen X SE24.30-9946.48%
CTMXCytomX Therapeutics Inc24.82-10158.46%
XOMAOXOMA Royalty Corp25.34-10370.68%
HALOHalozyme Therapeutics Inc25.62-10483.70%
XOMAPXOMA Royalty Corp25.67-10502.51%
VRTXVertex Pharmaceuticals Inc27.99-11444.53%
RPRXRoyalty Pharma plc - Class A28.69-11725.28%
SLNOSoleno Therapeutics Inc29.02-11858.12%
ASNDAscendis Pharma A/S30.09-12291.81%
LGNDLigand Pharmaceuticals Inc - Class B37.91-15463.39%
APLSApellis Pharmaceuticals Inc39.02-15912.89%
BMRNBiomarin Pharmaceutical Inc42.21-17205.85%
KRYSKrystal Biotech Inc45.34-18474.90%
ONCBeiGene Ltd69.54-28280.45%
PHARPharming Group N.V.75.03-30503.24%
TECHBio-Techne Corp101.96-41417.45%
VCELVericel Corp109.92-44644.35%
ALNYAlnylam Pharmaceuticals Inc117.96-47903.99%
GMABGenmab140.29-56951.21%
TLXTelix Pharmaceuticals Ltd162.15-65810.55%
CORTCorcept Therapeutics Inc212.86-86358.04%